Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionPrivate Advisor Group, LLC
Latest Disclosed Ownership8,433 shares
Latest Disclosed Value $ 3,765,536
Private Advisor Group, LLC ownership in VRTX / Vertex Pharmaceuticals Incorporated

On April 24, 2026 - Private Advisor Group, LLC filed a 13F-HR form disclosing ownership of 8,433 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $3,765,672 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 8,694 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -3.00% during the quarter. The current value of the position is $3,612,191 USD.

Private Advisor Group, LLC has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 8,433 -261 -3.00 3,766 -4.47 0.0167
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 8,694 1,330 18.06 3,941 36.70 0.0177
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 7,364 160 2.22 2,884 -10.10 0.0142
2025-08-11 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 7,204 -248 -3.33 3,207 -11.21 0.0173
2025-05-05 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 7,452 242 3.36 3,613 24.42 0.0219
2025-02-03 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 7,210 -34 -0.47 2,903 -13.83 0.0163
2024-10-22 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 7,244 -977 -11.88 3,369 -12.56 0.0209
2024-08-05 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 8,221 243 3.05 3,853 15.57 0.0258
2024-04-30 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 7,978 -2,343 -22.70 3,335 -20.60 0.0240
2024-02-06 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 10,321 500 5.09 4,199 22.96 0.0326
2023-11-03 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 9,821 -2,894 -22.76 3,415 -23.70 0.0305
2023-08-10 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 12,715 6,591 107.63 4,477 132.04 0.0389
2023-05-10 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,124 -1,193 -16.30 1,929 239.02 0.0184
2023-01-18 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 7,317 1,517 26.16 570 -66.11 0.0287
2022-10-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,800 -25,971 -81.74 1,679 -81.25 0.0193
2022-07-13 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 31,771 2,155 7.28 8,953 15.84 0.0799
2022-05-12 2022-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 29,616 -1,363 -4.40 7,729 13.61 0.0592
2022-05-10 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 30,979 0 6,803 0.0511
2022-02-10 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 30,979 -903 -2.83 6,803 17.64 0.0510
2021-10-14 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 31,882 3,955 14.16 5,783 2.70 0.0368
2021-08-12 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 27,927 16,382 141.90 5,631 127.06 0.0492
2021-04-22 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,545 1,389 13.68 2,480 3.33 0.0237
2021-04-01 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 10,156 1,162 12.92 2,400 -4.27 0.0250
2020-11-02 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 8,994 1,799 25.00 2,507 20.01 0.0326
2020-08-17 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 7,195 2,244 45.32 2,089 77.33 0.0290
2020-05-12 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,951 262 5.59 1,178 14.70 0.0216
2020-02-10 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,689 -920 -16.40 1,027 3.11 0.0160
2019-11-13 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,609 1,798 47.18 996 44.14 0.0155
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,811 -778 -16.95 691 -18.22 0.0125
2019-05-13 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,589 481 11.71 845 24.08 0.0167
2019-02-08 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,108 -1,054 -20.42 681 -31.56 0.0164
2018-11-01 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,162 1,680 48.25 995 68.36 0.0204
2018-08-09 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,482 1,036 42.35 591 48.12 0.0097
2018-05-09 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,446 -1,539 -38.62 399 -35.75 0.0156
2018-02-07 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,985 -1,948 -32.83 621 -32.57 0.0262
2017-11-13 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,933 476 8.72 921 31.20 0.0228
2017-08-10 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,457 129 2.42 702 15.65 0.0190
2017-05-10 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,328 94 1.80 607 41.82 0.0170
2017-02-09 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,234 -1 -0.02 428 -5.52 0.0140
2016-11-10 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,235 -659 -11.18 453 -14.20 0.0185
2016-08-09 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,894 929 18.71 528 40.05 0.0213
2016-05-13 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,965 -484 -8.88 377 -45.04 0.0182
2016-02-09 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,449 363 7.14 686 29.43 0.0329
2015-11-13 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,086 -1,166 -18.65 530 -31.35 0.0291
2015-08-13 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,252 1,091 21.14 772 26.77 0.0366
2015-05-13 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,161 3,250 170.07 609 168.28 0.0351
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,911 1,911 227 0.0146
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-06 2023-12-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-03 2023-09-30 13F VERTEX PHARMACEUTICALS COM Call 500 2 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.